Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Co-Diagnostics: No One-Hit Wonder
04:22pm, Friday, 04'th Jun 2021
Vaccine hesitancy and new coronavirus variants are a threat to herd immunity. The alternative solution to vaccination for re-opening the economy is mass testing.
5 Stocks To Watch For May 14, 2021
04:43am, Friday, 14'th May 2021
Some of the stocks that may grab investor focus today are: Walt Disney Co (NYSE: DIS) reported upbeat earnings for its second quarter, while sales missed expectations. Disney+ ended the second quarter
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2021 Results - Earnings Call Transcript
10:35pm, Thursday, 13'th May 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2021 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Beats Q1 Earnings and Revenue Estimates
07:41pm, Thursday, 13'th May 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 30.00% and 2.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Co-Diagnostics Q1 Earnings
05:21pm, Thursday, 13'th May 2021
Shares of Co-Diagnostics (NASDAQ:CODX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 620.00% year over year to $0.26, which
Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test
04:59pm, Thursday, 13'th May 2021
Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Smart COVID-19 Test. For the quarter ended March 31, th
CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: Should You Buy?
03:46pm, Thursday, 06'th May 2021
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast
09:30am, Tuesday, 04'th May 2021
SALT LAKE CITY, May 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, an
Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar
09:30am, Thursday, 29'th Apr 2021
SALT LAKE CITY, April 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic
Co-Diagnostics says its CoSara joint venture in India garnering media attention as it combats coronavirus surge
11:04am, Wednesday, 28'th Apr 2021
Co-Diagnostics Inc (NASDAQ:CODX) has noted that its Indian manufacturing facility, CoSara Diagnostics Pvt Ltd, has garnered media attention for its actions to provide much-needed coronavirus (COVID-1
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India
09:30am, Wednesday, 28'th Apr 2021
SALT LAKE CITY, April 28, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic
5 Health Care Stocks Trading with Low Price-Earnings Ratios
11:37am, Wednesday, 21'st Apr 2021
As of April 21, the GuruFocus All-in-One Screener, a Premium feature, found that the following guru-owned utilities have low price-earnings ratios. While some of them are great value investments, othe
Co-Diagnostics says Logix Smart COVID-19 Test performance validated by Australian researchers in peer-reviewed publication
11:10am, Tuesday, 20'th Apr 2021
Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company with a patented platform for the development of diagnostic tests, has revealed that its Logix Smart COVID-19 Test Kit was used by Aust
Co-Diagnostics, Inc. Test Performance Demonstrated by Australian Researchers in Peer-Reviewed Publication
09:30am, Tuesday, 20'th Apr 2021
SALT LAKE CITY, April 20, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announce
If You Rode the Co-Diagnostics Stock Pandemic Highs, It's Time to Bail
10:07am, Wednesday, 07'th Apr 2021
CODX stock rose on the pandemic, but its prospects moving forward look bleak with a sales strategy that is suspect at best. The post If You Rode the Co-Diagnostics Stock Pandemic Highs, It's Time to B
